Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 27% ± 12% | |
| endothelial cell | 5 studies | 18% ± 3% | |
| ciliated cell | 3 studies | 24% ± 5% | |
| dendritic cell | 3 studies | 19% ± 3% | |
| abnormal cell | 3 studies | 19% ± 1% | |
| basal cell | 3 studies | 18% ± 4% | |
| goblet cell | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5617.18 | 1445 / 1445 | 100% | 66.43 | 183 / 183 |
| ovary | 100% | 5990.71 | 180 / 180 | 100% | 59.00 | 430 / 430 |
| stomach | 100% | 5003.08 | 359 / 359 | 100% | 74.55 | 286 / 286 |
| uterus | 100% | 6470.44 | 170 / 170 | 100% | 90.97 | 459 / 459 |
| lung | 100% | 5842.03 | 578 / 578 | 100% | 80.83 | 1154 / 1155 |
| breast | 100% | 5877.71 | 459 / 459 | 100% | 91.32 | 1116 / 1118 |
| intestine | 100% | 6558.08 | 966 / 966 | 100% | 81.82 | 526 / 527 |
| prostate | 100% | 6304.67 | 245 / 245 | 100% | 69.46 | 501 / 502 |
| pancreas | 100% | 3421.33 | 327 / 328 | 100% | 71.15 | 178 / 178 |
| thymus | 100% | 6025.92 | 653 / 653 | 100% | 68.44 | 603 / 605 |
| brain | 100% | 3545.89 | 2635 / 2642 | 100% | 85.52 | 704 / 705 |
| skin | 100% | 6366.63 | 1809 / 1809 | 100% | 73.56 | 470 / 472 |
| bladder | 100% | 5972.81 | 21 / 21 | 99% | 80.04 | 500 / 504 |
| liver | 100% | 3656.50 | 226 / 226 | 99% | 43.85 | 402 / 406 |
| kidney | 100% | 4412.03 | 89 / 89 | 99% | 58.77 | 892 / 901 |
| adrenal gland | 100% | 4836.79 | 258 / 258 | 97% | 51.96 | 224 / 230 |
| adipose | 100% | 5455.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5057.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 95.31 | 29 / 29 |
| muscle | 100% | 4983.33 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7855.83 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 88.31 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 29.08 | 1 / 1 |
| heart | 99% | 2868.07 | 854 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 50.55 | 79 / 80 |
| peripheral blood | 98% | 4650.64 | 912 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0008380 | Biological process | RNA splicing |
| GO_0000354 | Biological process | cis assembly of pre-catalytic spliceosome |
| GO_0062176 | Biological process | R-loop processing |
| GO_0000375 | Biological process | RNA splicing, via transesterification reactions |
| GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
| GO_0005730 | Cellular component | nucleolus |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005682 | Cellular component | U5 snRNP |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0004386 | Molecular function | helicase activity |
| GO_0003724 | Molecular function | RNA helicase activity |
| GO_0003729 | Molecular function | mRNA binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| Gene name | DDX23 |
| Protein name | DEAD-box helicase 23 RNA helicase (EC 3.6.4.13) Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD) |
| Synonyms | |
| Description | FUNCTION: Involved in pre-mRNA splicing and its phosphorylated form (by SRPK2) is required for spliceosomal B complex formation . Independently of its spliceosome formation function, required for the suppression of incorrect R-loops formed during transcription; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA . . |
| Accessions | ENST00000552369.6 ENST00000551468.1 ENST00000703182.1 ENST00000703181.1 H0YI52 F8W1J5 H0YIL9 ENST00000552802.5 ENST00000703179.1 F8VVA2 A0A8V8TQQ5 A0A8V8TRI2 A0A8V8TR86 Q9BUQ8 ENST00000308025.8 [Q9BUQ8-1] ENST00000550834.1 A0A8V8TQ76 ENST00000552512.5 ENST00000547135.5 [Q9BUQ8-2] |